~~<i id='7CF54C8292'><strike id='7CF54C8292'><tt id='7CF54C8292'><pre id='7CF54C8292'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：comprehensive 2025-09-06 03:55:23 - browse：2696

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Neuroscience startup Neumora files for IPO

knowledge

entertainment

hotspot

leisure time

entertainment

Wikipedia

Inanewhealthalert,theCDCsaidcliniciansshouldprioritizeavailableBeyfortusdosesforbabiesathighestriskf

WSS

How a symptom of dementia informs our understanding of creativity

Emergency medicine has repudiated 'excited delirium.' Now what?

Traditional Chinese medicine benefits explored in new JAMA study

The pink breast cancer awareness ribbon needs a redesign

Study finds new variant for Parkinson’s in African populations

CDC recommends rationing of RSV shot due to shortages

hotspot

focus

knowledge

Moonlake's readout produced a cash windfall. Risks remain

First Opinion Podcast: How to protect health care in times of war

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Study finds new variant for Parkinson’s in African populations

New air purifier tech could be key to improving indoor air quality

Maker of FluMist seeks to allow at

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The pink breast cancer awareness ribbon needs a redesign

Walensky prepares to leave CDC — and Congress — behind

CDC advisory panel says seniors 'may' get RSV vaccine

entertainment

CDC recommends rationing of RSV shot due to shortages

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Readout Newsletter: XBI biotech index, Akero Therapeutics

FDA panel gives mixed vote on blood pressure devices

Neuroscience startup Neumora files for IPO

Cassava reveals details — and problems — with Alzheimer's study

hotspot

leisure time

entertainment

Wikipedia